Submitted by Anonymous (not verified) on 14 January 2026 - 13:30
Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 4, Status: Authorised